Status:
COMPLETED
Congenital Chagas Disease: Long Term Follow up of Treated Children. Preliminary Report or Cardiological Evaluation in Chagas Disease Treated Children
Lead Sponsor:
Hospital de Niños R. Gutierrez de Buenos Aires
Conditions:
Chagas Disease
Chagas Cardiomyopathy
Eligibility:
All Genders
6-50 years
Brief Summary
Chagas disease (CD) could be acquired by contact with the vector, transplacentally and by blood transfusion. The duration and clinical presentation of the initial acute phase of the infection may be v...
Eligibility Criteria
Inclusion
- Chagas diseases children treated with benznidazole / or nifurtimox
- Patients with at least 6 years of after-treatment follow-up.
- Diagnosis of Chagas disease: in infants younger than 8 months by direct observation of T.cruzi using parasitological concentration method (microhematocrit test); in infants older than 9 months 2 reactive serological test (ELISA, Indirect Hemagglutination ).
Exclusion
- Patients with chronic diseases (renal, hepatic, neurological) that at the discretion of the researcher could affect the interpretation of the results.
- Subjects with congenital heart disease.
Key Trial Info
Start Date :
January 22 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2020
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04090489
Start Date
January 22 2015
End Date
March 1 2020
Last Update
April 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Parasitology Division, Children's Hospital "R Gutierrez" of Buenos Aires
Buenos Aires, Argentina, 1425